Switching on the green light for chimeric antigen receptor T‐cell therapy-Reference-Cited by-同舟云学术

Switching on the green light for chimeric antigen receptor T‐cell therapy

Published:2019-01 Issue:5 Volume:8 Page:e1046
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Mardiana Sherly¹²,Lai Junyun¹²,House Imran Geoffrey¹²,Beavis Paul Andrew¹²,Darcy Phillip Kevin¹²³⁴

Affiliation:

1. Cancer Immunology Program Peter MacCallum Cancer Centre Melbourne VIC Australia

2. Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia

3. Department of Pathology University of Melbourne Parkville VIC Australia

4. Department of Immunology Monash University Clayton VIC Australia

Funder

National Health and Medical Research Council

Cancer Council Victoria

National Breast Cancer Foundation

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1046

Reference142 articles.

1. Coinhibitory Pathways in Immunotherapy for Cancer

2. Sustained remissions with CD19‐specific chimeric antigen receptor (CAR)‐modified T cells in children with relapsed/refractory ALL;Maude SL;ASCO Meeting Abstracts,2016

3. Engineering CAR-T cells: Design concepts

4. Efficacy of humanized CD19‐targeted chimeric antigen receptor (CAR)‐modified T cells in children and young adults with relapsed/refractory acute lymphoblastic leukemia;Maude SL;Blood,2016

5. Gene-engineered T cells for cancer therapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells;2024-06-27

2. Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products;Biomedicines;2022-06-14

3. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy;Nature Communications;2021-05-28

4. Toward precision immunotherapy using multiplex immunohistochemistry and in silico methods to define the tumor immune microenvironment;Cancer Immunology, Immunotherapy;2021-01-03

5. IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors;Molecular Therapy;2020-11